Variant report
Variant | nsv513270 |
---|---|
Chromosome Location | chr5:151580851-151584388 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs543292833 | chr5:151580853-151580854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs561919145 | chr5:151580876-151580877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs140908803 | chr5:151580922-151580923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs150400655 | chr5:151580932-151580933 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs169819 | chr5:151580934-151580935 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs138164466 | chr5:151581040-151581041 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs527648545 | chr5:151581078-151581079 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs35547294 | chr5:151581113-151581114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs186006333 | chr5:151581135-151581136 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs576104721 | chr5:151581185-151581186 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs142783793 | chr5:151581205-151581206 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190905639 | chr5:151581231-151581232 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs550155121 | chr5:151581243-151581244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368124791 | chr5:151581245-151581246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs372722401 | chr5:151581291-151581292 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183123108 | chr5:151581294-151581295 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs145035115 | chr5:151581316-151581317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs186450510 | chr5:151581342-151581343 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs547488042 | chr5:151581401-151581402 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565683753 | chr5:151581431-151581432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs190446770 | chr5:151581506-151581507 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375235376 | chr5:151581538-151581539 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs545504851 | chr5:151581547-151581548 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576307857 | chr5:151581620-151581621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs537332950 | chr5:151581643-151581644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558627782 | chr5:151581649-151581650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs707173 | chr5:151581680-151581681 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs573748168 | chr5:151581725-151581726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs541939180 | chr5:151581747-151581748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73798050 | chr5:151581748-151581749 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs572114109 | chr5:151581772-151581773 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs545830446 | chr5:151581837-151581838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531231324 | chr5:151581854-151581855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs138869430 | chr5:151581856-151581857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs142095374 | chr5:151581885-151581886 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs531939242 | chr5:151581918-151581919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs183063928 | chr5:151581944-151581945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs112844317 | chr5:151581949-151581950 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562159004 | chr5:151582033-151582034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs373719377 | chr5:151582065-151582066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs17663037 | chr5:151582105-151582106 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs187647712 | chr5:151582107-151582108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs11748796 | chr5:151582185-151582186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs13177923 | chr5:151582200-151582201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1422929 | chr5:151582211-151582212 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
46 | rs533056984 | chr5:151582224-151582225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs529211175 | chr5:151582247-151582248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs551426719 | chr5:151582257-151582258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs376180630 | chr5:151582289-151582290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs569620825 | chr5:151582309-151582310 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Hyperekplexia | 16941485 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Crohn''s disease | 20877625 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Breast cancer | 17603634 | CNVD |
Crohn''s disease | 20106866 | CNVD |
Breast cancer | 20409316 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:151573400-151581600 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
2 | chr5:151581600-151582400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
3 | chr5:151582800-151583400 | Enhancers | Stomach Mucosa | stomach |